Inclusion Criteria:
  -  Teicoplanin was administered intravenously;
  -  Teicoplanin was used for therapeutic purposes;
  -  Age:≤18 years;
  -  Clinician confirms and plans to diagnose the patient with gram-positive coccus infection;
  -  Patients with therapeutic concentration monitoring of teicoplanin.
Exclusion Criteria:
  -  Teicoplanin was administered non-intravenously;
  -  Teicoplanin was used for prophylactic purposes;
  -  Patients without therapeutic concentration monitoring of teicoplanin;
  -  Patients who die within 24 hours of the use of teicoplanin；
  -  The blood concentrations of the patient was not approved by the quality control center.